Changes in protein expression due to deleterious mutations in the FA/BRCA pathway

Biochem Biophys Res Commun. 2007 Dec 28;364(4):755-60. doi: 10.1016/j.bbrc.2007.10.025. Epub 2007 Oct 15.

Abstract

Inherited deleterious mutations in one of the Fanconi anemia genes lead to a disease, characterized by bone marrow failure, myeloid leukemia, and hypersensitivity to DNA damage. We identified proteins likely associated to the molecular signaling pathways involved in DNA repair of interstrand cross-link lesions and in mechanisms of genomic stability mediated by FA/BRCA pathways. We compared protein maps resolved by bidimensional electrophoresis and analyzed differentially expressed proteins, by mass spectrometry, between FA complementation group C (FANCC)-deficient cells, and their ectopically corrected counterpart in physiological conditions or after treatment with MMC. We found six differentially expressed proteins; among them, the checkpoint mediator protein MDC1 whose expression was disrupted in FANCC-/- cells. The potential role of differentially expressed proteins in FA phenotype is discussed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing
  • Apoptosis Regulatory Proteins
  • BRCA2 Protein / genetics*
  • Cell Cycle Proteins
  • Cell Line
  • DNA-Binding Proteins / genetics
  • Fanconi Anemia / genetics*
  • Fanconi Anemia Complementation Group C Protein / genetics*
  • Fanconi Anemia Complementation Group Proteins / genetics*
  • Gene Deletion
  • Gene Expression Regulation / genetics*
  • Humans
  • Mutagenesis, Site-Directed
  • Nuclear Proteins / genetics*
  • Signal Transduction / genetics*
  • Trans-Activators / genetics*

Substances

  • Adaptor Proteins, Signal Transducing
  • Apoptosis Regulatory Proteins
  • BLID protein, human
  • BRCA2 Protein
  • BRCA2 protein, human
  • Cell Cycle Proteins
  • DNA-Binding Proteins
  • FANCC protein, human
  • Fanconi Anemia Complementation Group C Protein
  • Fanconi Anemia Complementation Group Proteins
  • MDC1 protein, human
  • Nuclear Proteins
  • Trans-Activators